Cargando…

Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future

Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC) and comprises a chronic gastrointestinal tract disorder characterized by hyperactive and dysregulated immune responses to environmental factors, including gut microbiota and dietary components. An imbalance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Ellen Cristina Souza, Quaglio, Ana Elisa Valencise, Magro, Daniéla Oliveira, Di Stasi, Luiz Claudio, Sassaki, Ligia Yukie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138604/ https://www.ncbi.nlm.nih.gov/pubmed/37108339 http://dx.doi.org/10.3390/ijms24087176

Ejemplares similares

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2021)

MicroRNA expression in inflammatory bowel disease-associated colorectal cancer
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO(2) phytopharmaceutical preparation
por: Almeida Junior, Luiz Domingues, et al.
Publicado: (2017)

Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2023)

Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017)

How to Evaluate Fibrosis in IBD?
por: Tavares de Sousa, Helena, et al.
Publicado: (2023)

Effectiveness of Open Fenestration for Autosomal Dominant Polycystic Liver Disease
por: Norcia, Luiz Fernando, et al.
Publicado: (2022)

Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)

Inflammatory bowel disease epidemiology in São Paulo State, Brazil
por: Gasparini, Rodrigo Galhardi, et al.
Publicado: (2018)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
por: Norcia, Luiz Fernando, et al.
Publicado: (2022)

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
por: Ditto, Maria Chiara, et al.
Publicado: (2021)

Nutrition, gut microbiota and immunity: Therapeutic targets for IBD
por: Puri, A.S.
Publicado: (2016)

The gut microbiota heterogeneity and assembly changes associated with the IBD
por: Sun, Yang, et al.
Publicado: (2019)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask
por: Perez de Arce, Edith, et al.
Publicado: (2021)

Infliximab in young paediatric IBD patients: it is all about the dosing
por: Jongsma, Maria M. E., et al.
Publicado: (2020)

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients
por: Matijašić, Mario, et al.
Publicado: (2016)

Escherichia coli from Crohn’s disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes
por: da Silva Santos, Ana Carolina, et al.
Publicado: (2015)

Herpetic Esophagitis and Eosinophilic Esophagitis: A Potential Association
por: Quera, Rodrigo, et al.
Publicado: (2021)

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
por: de Souza, Letícia Rodrigues, et al.
Publicado: (2023)

Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist
por: Salwen-Deremer, Jessica K., et al.
Publicado: (2023)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells
por: Burrello, Claudia, et al.
Publicado: (2019)

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
por: Sassaki, Ligia Yukie, et al.
Publicado: (2022)

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD
por: Poletti, Martina, et al.
Publicado: (2020)

Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man
por: Xavier, José Cândido Caldeira, et al.
Publicado: (2013)

Small Intestinal Hemangioma: A Case Report
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2021)

IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine
por: Liu, Hongtao, et al.
Publicado: (2022)

Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
por: Xu, Xinwei, et al.
Publicado: (2023)

Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
por: Fiocchi, Claudio
Publicado: (2023)

Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research
por: Zhang, Shaocun, et al.
Publicado: (2017)

Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
por: Matijašić, Mario, et al.
Publicado: (2020)

New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
por: Larabi, Anaïs, et al.
Publicado: (2019)

Whole exome sequencing analyses reveal gene–microbiota interactions in the context of IBD
por: Hu, Shixian, et al.
Publicado: (2021)

Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
por: Dowdell, Alexander S., et al.
Publicado: (2021)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)—A Narrative Review
por: Légeret, Corinne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_81bff3rq12beuif8huhi0tf081